Zydus Lifesciences Limited has announced that its Board of Directors will meet on Tuesday, May 19, 2026, to evaluate a proposal for a share buyback. This strategic move, involving the repurchase of fully paid-up equity shares, will be deliberated during the upcoming board meeting. As part of the process, the company has implemented a temporary closure of its trading window to ensure compliance and market transparency regarding the potential buyback.
Upcoming Board Meeting
Zydus Lifesciences Limited is set to convene a meeting of its Board of Directors on May 19, 2026. The primary objective of this session is to discuss and evaluate a proposal for the buyback of fully paid-up equity shares. This potential corporate action is being pursued in accordance with standard legal provisions and frameworks governing the repurchase of securities.
Trading Window Update
In connection with this announcement, the company has updated its internal trading protocols. The trading window for all Directors and designated persons will remain closed until Thursday, May 21, 2026. Normal trading activities are scheduled to resume on Friday, May 22, 2026. These measures have been implemented to maintain professional standards and regulatory compliance while the buyback proposal is under formal consideration.
Source: BSE
